- Click on the title of each paper to access MedLine abstract at NLM site
Ulcerative Colitis - Medical treatment and research

                                                          <return>

Brackmann S, Andersen SN, Aamodt G, Langmark F, Clausen OP, Aadland E, Fausa O, Rydning A, Vatn MH.

Von Stein P, Lofberg R, Kuznetsov NV, Gielen AW, Persson JO, Sundberg R, Hellstrom K, Eriksson A, Befrits R, Ost A, Von Stein OD. Multigene Analysis Can Discriminate Between Ulcerative Colitis, Crohn's Disease, and Irritable Bowel Syndrome. Gastroenterology. 2008 Mar 2.

Hawthorne AB, Rubin G, Ghosh S. Review article: medication non-adherence in ulcerative colitis--strategies to improve adherence with mesalazine and other maintenance therapies. Aliment Pharmacol Ther. 2008 Jun;27(12):1157-66.

Harada A, Ohkusa T, Kushima K, Sakamoto M, Benno Y, Beppu K, Shibuya T, Sakamoto N, Watanabe S. Identification of bacteria from blood in febrile patients with ulcerative colitis by terminal restriction fragment length polymorphism profile analysis of 16S rRNA gene. Scand J Gastroenterol. 2008;43(4):423-30.

Lichtenstein GR, Kamm MA, Sandborn WJ, Lyne A, Joseph RE. MMX mesalazine for the induction of remission of mild-to-moderately active ulcerative colitis: efficacy and tolerability in specific patient subpopulations. Aliment Pharmacol Ther. 2008 Jun 1;27(11):1094-102.

Hart AR, Luben R, Olsen A, Tjonneland A, Linseisen J, Nagel G, Berglund G, Lindgren S, Grip O, Key T, Appleby P, Bergmann MM, Boeing H, Hallmans G, Danielsson A, Palmqvist R, Sjodin H, Hagglund G, Overvad K, Palli D, Masala G, Riboli E, Kennedy H, Welch A, Khaw KT, Day N, Bingham S. Diet in the aetiology of ulcerative colitis: a European prospective cohort study. Digestion. 2008;77(1):57-64.

Lutgens MW, Vleggaar FP, Schipper ME, Stokkers PC, van der Woude J, Hommes DW, de Jong DJ, Dijkstra G, van Bodegraven AA, Oldenburg B, Samsom M. High Frequency of Early Colorectal Cancer in Inflammatory Bowel Disease. Gut. 2008 Mar 12.

Lewis JD, Lichtenstein GR, Deren JJ, Sands BE, Hanauer SB, Katz JA, Lashner B, Present DH, Chuai S, Ellenberg JH, Nessel L, Wu GD; Rosiglitazone for Ulcerative Colitis Study Group. Rosiglitazone for active ulcerative colitis: a randomized placebo-controlled trial. Gastroenterology. 2008 Mar;134(3):688-95.

Hanai H, Iida T, Takeuchi K, Watanabe F, Maruyama Y, Kageoka M, Ikeya K, Yamada M, Kikuyama M, Iwaoka Y, Hirayama K, Nagata S, Sato Y, Hosoda Y. Intensive granulocyte and monocyte adsorption versus intravenous prednisolone in patients with severe ulcerative colitis: An unblinded randomised multi-centre controlled study. Dig Liver Dis. 2008 Jun;40(6):433-40.

James SL, Irving PM, Gearry RB, Gibson PR. Management of distal ulcerative colitis: frequently asked questions analysis. Intern Med J. 2008 Feb;38(2):114-9. Review.

Flasar MH, Quezada S, Bijpuria P, Cross RK. Racial Differences in Disease Extent and Severity in Patients with Ulcerative Colitis: A Retrospective Cohort Study. Dig Dis Sci. 2008 Feb 14.

Mitsuyama K, Sata M. Gut microflora: a new target for therapeutic approaches in inflammatory bowel disease. Expert Opin Ther Targets. 2008 Mar;12(3):301-12. Review.

Mahid SS, Mulhall AM, Gholson RD, Eichenberger MR, Galandiuk S. Inflammatory bowel disease and African Americans: A systematic review. Inflamm Bowel Dis. 2008 Feb 11.

Yamamoto T, Maruyama Y, Umegae S, Matsumoto K, Saniabadi AR. Mucosal inflammation in the terminal ileum of ulcerative colitis patients: endoscopic findings and cytokine profiles. Dig Liver Dis. 2008 Apr;40(4):253-9.

Baumgart DC. What's new in inflammatory bowel disease in 2008? World J Gastroenterol. 2008 Jan 21;14(3):329-30.

Kane SV, Reddy D. Hormonal replacement therapy after menopause is protective of disease activity in women with inflammatory bowel disease. Am J Gastroenterol. 2008 May;103(5):1193-6.

Xiang JY, Ouyang Q, Li GD, Xiao NP. Clinical value of fecal calprotectin in determining disease activity of ulcerative colitis. World J Gastroenterol. 2008 Jan 7;14(1):53-7.

Melmed GY, Fleshner PR, Bardakcioglu O, Ippoliti A, Vasiliauskas EA, Papadakis KA, Dubinsky M, Landers C, Rotter JI, Targan SR. Family history and serology predict Crohn's disease after ileal pouch-anal anastomosis for ulcerative colitis. Dis Colon Rectum. 2008 Jan;51(1):100-8.

Swidsinski A, Loening-Baucke V, Vaneechoutte M, Doerffel Y. Active Crohn's disease and ulcerative colitis can be specifically diagnosed and monitored based on the biostructure of the fecal flora. Inflamm Bowel Dis. 2008 Feb;14(2):147-61.

Rhodes JM, Robinson R, Beales I, Pugh S, Dickinson R, Dronfield M, Speirs CJ, Wilkinson P, Wilkinson SP. Clinical trial: oral prednisolone metasulfobenzoate (Predocol) vs. oral prednisolone for active ulcerative colitis. Aliment Pharmacol Ther. 2008 Feb 1;27(3):228-40.

Flasar MH, Johnson T, Roghmann MC, Cross RK. Disparities in the use of immunomodulators and biologics for the treatment of inflammatory bowel disease: a retrospective cohort study. Inflamm Bowel Dis. 2008 Jan;14(1):13-9.

Oliveira GR, Teles BC, Brasil EF, Souza MH, Furtado LE, de Castro-Costa CM, Rola FH, Braga LL, Gondim Fde A. Peripheral neuropathy and neurological disorders in an unselected Brazilian population-based cohort of IBD patients. Inflamm Bowel Dis. 2008 Mar;14(3):389-95.

Cappell MS, Turkieh A. Chronic pericarditis and pericardial tamponade associated with ulcerative colitis. Dig Dis Sci. 2008 Jan;53(1):149-54.

Gavalas E, Kountouras J, Stergiopoulos C, Zavos C, Gisakis D, Nikolaidis N, Giouleme O, Chatzopoulos D, Kapetanakis N. Efficacy and safety of infliximab in steroid-dependent ulcerative colitis patients. Hepatogastroenterology. 2007 Jun;54(76):1074-9.

Jones JL, Loftus EV Jr.  Lymphoma risk in inflammatory bowel disease: Is it the disease or its treatment? Inflamm Bowel Dis. 2007 Jun 28

Katsanos KH, Vermeire S, Christodoulou DK, Riis L, Wolters F, Odes S, Freitas J, Hoie O, Beltrami M, Fornaciari G, Clofent J, Bodini P, Vatn M, Nunes PB, Moum B, Munkholm P, Limonard C, Stockbrugger R, Rutgeerts P, Tsianos EV. Dysplasia and Cancer in Inflammatory Bowel Disease 10 Years after Diagnosis: Results of a Population-Based European Collaborative Follow-Up Study.
Digestion. 2007 Jun 26;75(2-3):113-

Cooney RM, Warren BF, Altman DG, Abreu MT, Travis SP.  Outcome measurement in clinical trials for Ulcerative Colitis: towards standardisation. Trials. 2007 Jun 25;8:17.

Lorea Baroja M, Kirjavainen PV, Hekmat S, Reid G.  Anti-inflammatory effects of probiotic yogurt in inflammatory bowel disease patients. Clin Exp Immunol. 2007 Jun 22

Hoie O, Wolters F, Riis L, Aamodt G, Solberg C, Bernklev T, Odes S, Mouzas IA, Beltrami M, Langholz E, Stockbrugger R, Vatn M, Moum B; on behalf of the European Collaborative Study Group of Inflammatory Bowel Disease (EC-IBD).  Ulcerative Colitis: Patient Characteristics May Predict 10-Yr Disease Recurrence in a European-Wide Population-Based Cohort.
Am J Gastroenterol. 2007 Jun 7;

Langhorst J, Mueller T, Luedtke R, Franken U, Paul A, Michalsen A, Schedlowski M, Dobos GJ, Elsenbruch S.  Effects of a comprehensive lifestyle modification program on quality-of-life in patients with ulcerative colitis: a twelve-month follow-up.
Scand J Gastroenterol. 2007 Jun;42(6):734-45

Nuding S, Fellermann K, Wehkamp J, Stange EF.  Reduced mucosal antimicrobial activity in Crohn's disease of the colon.
Gut. 2007 Apr 24;

Ferrante M, Henckaerts L, Joossens M, Pierik M, Joossens S, Dotan N, Norman G, Altstock R, Van Steen K, Rutgeerts P, Van Assche G, Vermeire S.  New serological markers in inflammatory bowel disease are associated with complicated disease behaviour. Gut. 2007 Apr 24;

Yokoyama H, Takagi S, Kuriyama S, Takahashi S, Takahashi H, Iwabuchi M, Takahashi S, Kinouchi Y, Hiwatashi N, Tsuji I, Shimosegawa T.  Effect of weekend 5-aminosalicylic acid (mesalazine) enema as maintenance therapy for ulcerative colitis: Results from a randomized controlled study.
Inflamm Bowel Dis. 2007 Apr 23;

Rubin DT, Rothe JA, Hetzel JT, Cohen RD, Hanauer SB.  Are dysplasia and colorectal cancer endoscopically visible in patients with ulcerative colitis? Gastrointest Endosc. 2007 Jun;65(7):998-1004.  

Scarpa M, van Koperen PJ, Ubbink DT, Hommes DW, Ten Kate FJ, Bemelman WA.  Systematic review of dysplasia after restorative proctocolectomy for ulcerative colitis.
Br J Surg. 2007 May;94(5):534-45.

Jakobovits SL, Jewell DP, Travis SP.  Infliximab for the treatment of ulcerative colitis: outcomes in Oxford from 2000 to 2006.
Aliment Pharmacol Ther. 2007 May 1;25(9):1055-60.

Rodgers AD, Cummins AG.  CRP Correlates with Clinical Score in Ulcerative Colitis but Not in Crohn's Disease.
Dig Dis Sci. 2007 Apr 11;

Turk N, Kastelan D, Cukovic-Cavka S, Kraljevic I, Korsic M, Vucelic B.  Discriminatory ability of calcaneal quantitative ultrasound in the assessment of bone status in patients with inflammatory bowel disease. Ultrasound Med Biol. 2007 Jun;33(6):863-9.

Rahimi R, Nikfar S, Rezaie A, Abdollahi M.  A Meta-Analysis of Antibiotic Therapy for Active Ulcerative Colitis.
Dig Dis Sci. 2007 Apr 6;

McHugh JB, Appelman HD, McKenna BJ.  The diagnostic value of endoscopic terminal ileum biopsies. Am J Gastroenterol. 2007 May;102(5):1084-9.

Bortoli A, Saibeni S, Tatarella M, Prada A, Beretta L, Rivolta R, Politi P, Ravelli P, Imperiali G, Colombo E, Pera A, Daperno M, Carnovali M, de Franchis R, Vecchi M; the Study Group for Inflammatory Bowel Diseases GSMII. Angriman I, Scarpa M, D'Inca R, Basso D, Ruffolo C, Polese L, Sturniolo GC, D'Amico DF, Plebani M.  Enzymes in feces: useful markers of chronic inflammatory bowel disease.
Clin Chim Acta. 2007 May;381(1):63-8.

de Bievre MA, Vrij AA, Schoon EJ, Dijkstra G, de Jong AE, Oberndorff-Klein Woolthuis AH, Hemker HC, Stockbrugger RW. Randomized, placebo-controlled trial of low molecular weight heparin in active ulcerative colitis. Inflamm Bowel Dis. 2007 Jun;13(6):753-8.

Jess T, Riis L, Vind I, Winther KV, Borg S, Binder V, Langholz E, Thomsen OO, Munkholm P.  Changes in clinical characteristics, course, and prognosis of inflammatory bowel disease during the last 5 decades: a population-based study from Copenhagen, Denmark. Inflamm Bowel Dis. 2007 Apr;13(4):481-9.

Terdiman JP, Steinbuch M, Blumentals WA, Ullman TA, Rubin DT.  5-Aminosalicylic acid therapy and the risk of colorectal cancer among patients with inflammatory bowel disease. Inflamm Bowel Dis. 2007 Apr;13(4):367-71.

Cornish J, Tan E, Teare J, Teoh TG, Rai R, Clark SK, Tekkis PP.  A meta-analysis on the influence of inflammatory bowel disease on pregnancy. Gut. 2007 Jun;56(6):830-7. Epub 2006 Dec 21.

Jiang L, Xia B, Li J, Ye M, Deng C, Ding Y, Luo H, Ren H, Hou X, Liu H, Xu H, Cheng H, Yang H. Risk factors for ulcerative colitis in a Chinese population: an age-matched and sex-matched case-control study.
J Clin Gastroenterol. 2007 Mar;41(3):280-4.

Meisner RS, Spier BJ, Einarsson S, Roberson EN, Perlman SB, Bianco JA, Taylor AJ, Einstein M, Jaskowiak CJ, Massoth KM, Reichelderfer M. Pilot study using PET/CT as a novel, noninvasive assessment of disease activity in inflammatory bowel disease. Inflamm Bowel Dis. 2007 Mar 29;

McHugh JB, Appelman HD, McKenna BJ. The Diagnostic Value of Endoscopic Terminal Ileum Biopsies.
Am J Gastroenterol. 2007 Mar 27;

Bresci G, Parisi G, Mazzoni A, Scatena F, Capria A. Treatment of patients with acute ulcerative colitis: Conventional corticosteroid therapy (MP) versus granulocytapheresis (GMA): A pilot study.
Dig Liver Dis. 2007 May;39(5):430-4.  

Takemoto K, Kato J, Kuriyama M, Nawa T, Kurome M, Okada H, Sakaguchi K, Shiratori Y.Predictive factors of efficacy of leukocytapheresis for steroid-resistant ulcerative colitis patients. Dig Liver Dis. 2007 May;39(5):422-9.

Hookey LC, Hurlbut DJ, Day AG, Manley PN, Depew WT. One bite or two? A prospective trial comparing colonoscopy biopsy technique in patients with chronic ulcerative colitis. Can J Gastroenterol. 2007 Mar;21(3):164-8.

Angriman I, Scarpa M, D'Inca R, Basso D, Ruffolo C, Polese L, Sturniolo GC, D'Amico DF, Plebani M. Enzymes in feces: Useful markers of chronic inflammatory bowel disease.
Clin Chim Acta. 2007 Feb 21;

Komanduri S, Gillevet PM, Sikaroodi M, Mutlu E, Keshavarzian A. Dysbiosis in pouchitis: evidence of unique microfloral patterns in pouch inflammation.
Clin Gastroenterol Hepatol. 2007 Mar;5(3):352-60.

Biancone L, Gionchetti P, Blanco Gdel V, Orlando A, Annese V, Papi C, Sostegni R, D'Inca R, Petruzziello C, Casa A, Sica G, Calabrese E, Campieri M, Pallone F. Beclomethasone dipropionate versus mesalazine in distal ulcerative colitis: A multicenter, randomized, double-blind study. Dig Liver Dis. 2007 Apr;39(4):329-37.

Tuvlin JA, Raza SS, Bracamonte S, Julian C, Hanauer SB, Nicolae DL, King AC, Cho JH. Smoking and inflammatory bowel disease: Trends in familial and sporadic cohorts.
Inflamm Bowel Dis. 2007 Mar 7;13(5):573-579

Aldhous MC, Drummond HE, Anderson N, Baneshi MR, Smith LA, Arnott ID, Satsangi J. Smoking habit and load influence age at diagnosis and disease extent in ulcerative colitis. Am J Gastroenterol. 2007 Mar;102(3):589-97.

Miki C, Ohmori Y, Yoshiyama S, Toiyama Y, Araki T, Uchida K, Kusunoki M. Factors predicting postoperative infectious complications and early induction of inflammatory mediators in ulcerative colitis patients.
World J Surg. 2007 Mar;31(3):522-9.

Strober W, Fuss I, Mannon P. The fundamental basis of inflammatory bowel disease. J Clin Invest. 2007 Mar;117(3):514-21. Review.

Ljung T, Thomsen OO, Vatn M, Karlen P, Karlsen LN, Tysk C, Nilsson SU, Kilander A, Gillberg R, Grip O, Lindgren S, Befrits R, Lofberg R. Granulocyte, monocyte/macrophage apheresis for inflammatory bowel disease: the first 100 patients treated in Scandinavia. Scand J Gastroenterol. 2007 Feb;42(2):221-7.

Feagan BG, Reinisch W, Rutgeerts P, Sandborn WJ, Yan S, Eisenberg D, Bala M, Johanns J, Olson A, Hanauer SB. The effects of infliximab therapy on health-related quality of life in ulcerative colitis patients. Am J Gastroenterol. 2007 Apr;102(4):794-802.

Yantiss RK, Odze RD. Pitfalls in the interpretation of nonneoplastic mucosal biopsies in inflammatory bowel disease. Am J Gastroenterol. 2007 Apr;102(4):890-904

Thomas T, Abrams KA, Robinson RJ, Mayberry JF. Meta-analysis: cancer risk of low-grade dysplasia in chronic ulcerative colitis. Aliment Pharmacol Ther. 2007 Mar 15;25(6):657-68.

Subramanian V, Banerjee A, Beharry N, Farthing MJ, Pollok RC. Determining the proximal extent of ulcerative colitis: white cell scan correlates well with histological assessment. Aliment Pharmacol Ther. 2007 Feb 15;25(4):441-6.

de Bievre MA, Vrij AA, Schoon EJ, Dijkstra G, de Jong AE, Oberndorff-Klein Woolthuis AH, Hemker HC, Stockbrugger RW. Randomized, placebo-controlled trial of low molecular weight heparin in active ulcerative colitis.
Inflamm Bowel Dis. 2007 Jan 26;13(6):753-758

Su C, Lewis JD, Goldberg B, Brensinger C, Lichtenstein GR. A meta-analysis of the placebo rates of remission and response in clinical trials of active ulcerative colitis. Gastroenterology. 2007 Feb;132(2):516-26.  

Timmer A, McDonald JW, Macdonald JK. Azathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitis. Cochrane Database Syst Rev. 2007 Jan 24;(1):CD000478. Review.

Gisbert JP, Gonzalez-Lama Y, Mate J. Systematic review: Infliximab therapy in ulcerative colitis. Aliment Pharmacol Ther. 2007 Jan 1;25(1):19-37.

Ng SC, Arebi N, Kamm MA. Medium-term results of oral tacrolimus treatment in refractory inflammatory bowel disease. Inflamm Bowel Dis. 2007 Feb;13(2):129-34.

Menees S, Higgins P, Korsnes S, Elta G. Does colonoscopy cause increased ulcerative colitis symptoms? Inflamm Bowel Dis. 2007 Jan;13(1):12-8.

Masunaga Y, Ohno K, Ogawa R, Hashiguchi M, Echizen H, Ogata H. Meta-analysis of risk of malignancy with immunosuppressive drugs in inflammatory bowel disease. Ann Pharmacother. 2007 Jan;41(1):21-8.

Makharia GK, Sachdev V, Gupta R, Lal S, Pandey RM. Anti-Saccharomyces cerevisiae antibody does not differentiate between Crohn's disease and intestinal tuberculosis. Dig Dis Sci. 2007 Jan;52(1):33-9.

Jess T, Gamborg M, Munkholm P, Sorensen TI. Overall and cause-specific mortality in ulcerative colitis: meta-analysis of population-based inception cohort studies.
Am J Gastroenterol. 2007 Mar;102(3):609-17.

Bossa F, Fiorella S, Caruso N, Accadia L, Napolitano G, Valvano MR, Andriulli A, Annese V. Continuous infusion versus bolus administration of steroids in severe attacks of ulcerative colitis: a randomized, double-blind trial.
Am J Gastroenterol. 2007 Mar;102(3):601-8.

Turner D, Walsh CM, Steinhart AH, Griffiths AM. Response to corticosteroids in severe ulcerative colitis: a systematic review of the literature and a meta-regression. Clin Gastroenterol Hepatol. 2007 Jan;5(1):103-10.

Brunner B, Scheurer U, Seibold F. Differences in yeast intolerance between patients with Crohn's disease and ulcerative colitis. Dis Colon Rectum. 2007 Jan;50(1):83-8.

Castro M, Papadatou B, Ceriati E, Knafelz D, De Angelis P, Ferretti F, Gambarara M, Diamanti A, De Peppo F, Rivosecchi M. Role of cyclosporin in preventing or delaying colectomy in children with severe ulcerative colitis. Langenbecks Arch Surg. 2007 Mar;392(2):161-4.

Su C, Lewis JD, Goldberg B, Brensinger C, Lichtenstein GR. A Meta-Analysis of the Placebo Rates of Remission and Response in Clinical Trials of Active Ulcerative Colitis. Gastroenterology. 2006 Dec 20;

Familiari L, Strangio G, Consolo P, Luigiano C, Bonica M, Barresi G, Barresi V, Familiari P, D'Arrigo G, Alibrandi A, Zirilli A, Fries W, Scaffidi M. Optical coherence tomography evaluation of ulcerative colitis: the patterns and the comparison with histology.
Am J Gastroenterol. 2006 Dec;101(12):2833-40.

Jess T, Riis L, Vind I, Winther KV, Borg S, Binder V, Langholz E, Thomsen OO, Munkholm P. Changes in clinical characteristics, course, and prognosis of inflammatory bowel disease during the last 5 decades: A population-based study from Copenhagen, Denmark. Inflamm Bowel Dis. 2006 Dec 19;

Ferrante M, Vermeire S, Katsanos KH, Noman M, Van Assche G, Schnitzler F, Arijs I, De Hertogh G, Hoffman I, Geboes K, Rutgeerts P. Predictors of early response to infliximab in patients with ulcerative colitis. Inflamm Bowel Dis. 2006 Dec 19;

Cornish JA, Tan EK, Teare J, Teoh TG, Rai R, Clark SK, Tekkis PP. A Meta-analysis on the Influence of Inflammatory Bowel Disease on Pregnancy. Gut. 2006 Dec 21; [

Jess T, Gamborg M, Munkholm P, Sorensen TI. Overall and Cause-Specific Mortality in Ulcerative Colitis: Meta-analysis of Population-Based Inception Cohort Studies. Am J Gastroenterol. 2006 Dec 11;

Bossa F, Fiorella S, Caruso N, Accadia L, Napolitano G, Valvano MR, Andriulli A, Annese V. Continuous Infusion Versus Bolus Administration of Steroids in Severe Attacks of Ulcerative Colitis: A Randomized, Double-Blind Trial. Am J Gastroenterol. 2006 Dec 11;

Sood A, Midha V, Sood N, Bansal M. Long term results of use of azathioprine in patients with ulcerative colitis in India.
World J Gastroenterol. 2006 Dec 7;12(45):7332-6.

Turner D, Walsh CM, Steinhart AH, Griffiths AM. Response to corticosteroids in severe ulcerative colitis: a systematic review of the literature and a meta-regression. Clin Gastroenterol Hepatol. 2007 Jan;5(1):103-10.

Ha JS, Lee JS, Kim HJ, Moon TG, Chang DK, Lee JH, Kim YH, Rhee PL, Kim JJ, Rhee JC. Comparative usefulness of erythrocyte sedimentation rate and C-reactive protein in assessing the severity of ulcerative colitis] Korean J Gastroenterol. 2006 Nov;48(5):313-20.

Vergara T, Cofre P, Cifuentes S, Pulgar U, Puebla C, Velasco S. [Presence of antineutrophil cytoplasmic antibodies (ANCA) and anti Saccharomyces cerevisiae antibodies (ASCA) among patients with ulcerative colitis] Rev Med Chil. 2006 Aug;134(8):960-4.

Mahid SS, Minor KS, Soto RE, Hornung CA, Galandiuk S. Smoking and inflammatory bowel disease: a meta-analysis. Mayo Clin Proc. 2006 Nov;81(11):1462-71.

Weber A, Fein F, Koch S, Dupont-Gossart AC, Mantion G, Heyd B, Carbonnel F. Treatment of ulcerative colitis refractory to steroid therapy by oral microemulsion cyclosporine (Neoral).
Inflamm Bowel Dis. 2006 Dec;12(12):1131-5.

Loftus EV Jr. A practical perspective on ulcerative colitis: patients' needs from aminosalicylate therapies. Inflamm Bowel Dis. 2006 Dec;12(12):1107-13.

Lerebours E, Gower-Rousseau C, Merle V, Brazier F, Debeugny S, Marti R, Salomez JL, Hellot MF, Dupas JL, Colombel JF, Cortot A, Benichou J. Stressful Life Events as a Risk Factor for Inflammatory Bowel Disease Onset: A Population-Based Case-Control Study.
Am J Gastroenterol. 2006 Nov 13;

Chung GE, Cheon JH, Lee JY, Ye BD, Kim SG, Kim JS, Jung HC, Song IS.[Efficacy of combination of intravenous cyclosporin A and steroid therapy versus prolonged intravenous steroid therapy alone in patients with severe ulcerative colitis refractory to initial intravenous steroid therapy] Korean J Gastroenterol. 2006 Oct;48(4):263-8.

Rubin DT, LoSavio A, Yadron N, Huo D, Hanauer SB. Aminosalicylate therapy in the prevention of dysplasia and colorectal cancer in ulcerative colitis. Clin Gastroenterol Hepatol. 2006 Nov;4(11):1346-50.

Hoie O, Schouten L, Wolters F, Solberg C, Riis L, Mouzas I, Politi P, Odes S, Langholz E, Vatn M, Stockbrugger R, Moum B. Ulcerative colitis: no rise in mortality in a European-wide population-based cohort 10 years after diagnosis.
Gut. 2006 Oct 6;

Regueiro M, Loftus EV Jr, Steinhart AH, Cohen RD. Medical management of left-sided ulcerative colitis and ulcerative proctitis: critical evaluation of therapeutic trials. Inflamm Bowel Dis. 2006 Oct;12(10):979-94.

Regueiro M, Loftus EV Jr, Steinhart AH, Cohen RD. Clinical guidelines for the medical management of left-sided ulcerative colitis and ulcerative proctitis: summary statement.
Inflamm Bowel Dis. 2006 Oct;12(10):972-8.

Hanauer SB. Review article: high-dose aminosalicylates to induce and maintain remissions in ulcerative colitis.
Aliment Pharmacol Ther. 2006 Oct;24 Suppl 3:37-40.

Waljee A, Waljee J, Morris AM, Higgins PD. Threefold increased risk of infertility: a meta-analysis of infertility after ileal pouch anal anastomosis in ulcerative colitis. Gut. 2006 Nov;55(11):1575-80.

Ding YJ, Yu JP, Luo HS, Zhou ZY, Liu J. Evaluation and analysis of colonoscopy in the diagnosis of 186 cases of ulcerative colitis patients. Int J Clin Pract. 2006 Nov;60(11):1408-10.

Ikeuchi H, Hori K, Nishigami T, Nakano H, Uchino M, Nakamura M, Kaibe N, Noda M, Yanagi H, Yamamura T. Diffuse gastroduodenitis and pouchitis associated with ulcerative colitis. World J Gastroenterol. 2006 Sep 28;12(36):5913-5.

Okada H, Makidono C, Takenaka R, Hiraoka S, Fujiwara A, Kato J, Kawahara Y, Kawamoto H, Mizuno M, Shiratori Y. Therapeutic Efficacy of Leukocytapheresis in a Pregnant Woman with Severe Active Ulcerative Colitis. Digestion. 2006 Aug 29;74(1):15-18

Sands BE, Kilgore KM, Bloomfeld RS, Sandborn WJ. Variation in severity assessment and initial mesalamine dose selection for ulcerative colitis in community practice. J Clin Gastroenterol. 2006 Aug;40(7):587-91.

Mawdsley JE, Macey MG, Feakins RM, Langmead L, Rampton DS. The effect of acute psychologic stress on systemic and rectal mucosal measures of inflammation in ulcerative colitis. Gastroenterology. 2006 Aug;131(2):410-9.

Bernal I, Manosa M, Domenech E, Garcia-Planella E, Navarro M, Lorenzo-Zuniga V, Cabre E, Gassull MA. Predictors of clinical response to systemic steroids in active ulcerative colitis.
Dig Dis Sci. 2006 Aug;51(8):1434-8.

Kornbluth A, Hayes M, Feldman S, Hunt M, Fried-Boxt E, Lichtiger S, Legnani P, George J, Young J. Do guidelines matter? Implementation of the ACG and AGA osteoporosis screening guidelines in inflammatory bowel disease (IBD) patients who meet the guidelines' criteria. Am J Gastroenterol. 2006 Jul;101(7):1546-50.

Riis L, Vind I, Politi P, Wolters F, Vermeire S, Tsianos E, Freitas J, Mouzas I, Ruiz Ochoa V, O'Morain C, Odes S, Binder V, Moum B, Stockbrugger R, Langholz E, Munkholm P; European Collaborative study group on Inflammatory Bowel Disease. Does pregnancy change the disease course? A study in a European cohort of patients with inflammatory bowel disease. Am J Gastroenterol. 2006 Jul;101(7):1539-45.

Bibiloni R, Mangold M, Madsen KL, Fedorak RN, Tannock GW. The bacteriology of biopsies differs between newly diagnosed, untreated, Crohn's disease and ulcerative colitis patients. J Med Microbiol. 2006 Aug;55(Pt 8):1141-9.

Ho GT, Chiam P, Drummond H, Loane J, Arnott ID, Satsangi J. The efficacy of corticosteroid therapy in inflammatory bowel disease: analysis of a 5-year UK inception cohort. Aliment Pharmacol Ther. 2006 Jul 15;24(2):319-30.

Zilberman L, Maharshak N, Arbel Y, Rogowski O, Rozenblat M, Shapira I, Berliner S, Arber N, Dotan I. Correlated expression of high-sensitivity C-reactive protein in relation to disease activity in inflammatory bowel disease: lack of differences between Crohn's disease and ulcerative colitis. Digestion. 2006;73(4):205-9.

Arseneau KO, Sultan S, Provenzale DT, Onken J, Bickston SJ, Foley E, Connors AF Jr, Cominelli F. Do patient preferences influence decisions on treatment for patients with steroid-refractory ulcerative colitis? Clin Gastroenterol Hepatol. 2006 Sep;4(9):1135-42.

Regueiro M, Curtis J, Plevy S. Infliximab for hospitalized patients with severe ulcerative colitis. J Clin Gastroenterol. 2006 Jul;40(6):476-81.

Henriksen M, Jahnsen J, Lygren I, Sauar J, Kjellevold O, Schulz T, Vatn MH, Moum B; IBSEN Study Group. Ulcerative colitis and clinical course: results of a 5-year population-based follow-up study (the IBSEN study). Inflamm Bowel Dis. 2006 Jul;12(7):543-50.

Picco MF, Krishna M, Cangemi JR, Shelton D. Oral mesalamine and clinical remission are associated with a decrease in the extent of long-standing ulcerative colitis. Inflamm Bowel Dis. 2006 Jul;12(7):537-42.

Rutter MD, Saunders BP, Wilkinson KH, Schofield G, Forbes A. Intangible costs and benefits of ulcerative colitis surveillance: a patient survey. Dis Colon Rectum. 2006 Aug;49(8):1177-83.

Wolters FL, Russel MG, Sijbrandij J, Schouten LJ, Odes S, Riis L, Munkholm P, Langholz E, Bodini P, O'morain C, Katsanos K, Tsianos E, Vermeire S, Van Zeijl G, Limonard C, Hoie O, Vatn M, Moum B, W Stockbrugger R, On Behalf Of The European Collaborative Study Group On Inflammatory Bowel Disease Ec-Ibd. Disease outcome of inflammatory bowel disease patients: General outline of a Europe-wide population-based 10-year clinical follow-up study. Scand J Gastroenterol Suppl. 2006 May;(243):46-54. 

Siegel CA, Sands BE. Risk factors for colorectal cancer in Crohn's colitis: a case-control study. Inflamm Bowel Dis. 2006 Jun;12(6):491-6. 

Halme L, Paavola-Sakki P, Turunen U, Lappalainen M, Farkkila M, Kontula K. Family and twin studies in inflammatory bowel disease. World J Gastroenterol. 2006 Jun 21;12(23):3668-72.  

Vind I, Riis L, Jess T, Knudsen E, Pedersen N, Elkjaer M, Bak Andersen I, Wewer V, Norregaard P, Moesgaard F, Bendtsen F, Munkholm P; the DCCD study group. Increasing incidences of inflammatory bowel disease and decreasing surgery rates in Copenhagen City and County, 2003-2005: a population-based study from the Danish Crohn colitis database. Am J Gastroenterol. 2006 Jun;101(6):1274-82. 

Fallingborg JF.  [Does 5-ASA prevent development of colon cancer in ulcerative colitis?] Ugeskr Laeger. 2006 May 22;168(21):2049-51. Review. Danish.  

Ochsenkuhn T, Tillack C, Stepp H, Diebold J, Ott SJ, Baumgartner R, Brand S, Goke B, Sackmann M. Low frequency of colorectal dysplasia in patients with long-standing inflammatory bowel disease colitis: detection by fluorescence endoscopy.
Endoscopy. 2006 May;38(5):477-82.  

Danese S, Sans M, de la Motte C, Graziani C, West G, Phillips MH, Pola R, Rutella S, Willis J, Gasbarrini A, Fiocchi C.  Angiogenesis as a novel component of inflammatory bowel disease pathogenesis. Gastroenterology. 2006 Jun;130(7):2060-73.

Velayos FS, Loftus EV Jr, Jess T, Harmsen WS, Bida J, Zinsmeister AR, Tremaine WJ, Sandborn WJ. Predictive and protective factors associated with colorectal cancer in ulcerative colitis: A case-control study. Gastroenterology. 2006 Jun;130(7):1941-9.  

Jaskowski TD, Litwin CM, Hill HR. Analysis